SCOPUS 정보 검색 플랫폼

Orthopedics

Volumn 32, Issue 11, 2009, Pages 835-838

Malignant hyperthermia: A pharmacogenetic disorder

(3) Stratman, Rachel C a Flynn, Jeremy D b Hatton, Kevin W c

a BARNES JEWISH HOSPITAL (United States)

b UNIVERSITY OF KENTUCKY (United States)

c UNIVERSITY OF KENTUCKY (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE; BICARBONATE; BUPIVACAINE; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; DANTROLENE; DESFLURANE; DILTIAZEM; DIURETIC AGENT; ENFLURANE; ETOMIDATE; GLUCOSE; HALOTHANE; HYPERTENSIVE FACTOR; INOTROPIC AGENT; INSULIN; ISOFLURANE; LIDOCAINE; LOCAL ANESTHETIC AGENT; NEUROMUSCULAR BLOCKING AGENT; NITROUS OXIDE; OPIATE; PROPOFOL; SEVOFLURANE; SUXAMETHONIUM; UNINDEXED DRUG; VERAPAMIL; CENTRAL MUSCLE RELAXANT; RYANODINE RECEPTOR;

ARTICLE; CLINICAL FEATURE; DISEASE PREDISPOSITION; DIZZINESS; DROWSINESS; EARLY DIAGNOSIS; GENE MUTATION; GENETIC ASSOCIATION; GRIP STRENGTH; HEALTH CARE PERSONNEL; HEART ARRHYTHMIA; HUMAN; HYPERKALEMIA; HYPERTHERMIA; INJECTION SITE ERYTHEMA; INJECTION SITE EXTRAVASATION; INJECTION SITE PAIN; INJECTION SITE REACTION; INJECTION SITE SWELLING; MALIGNANT HYPERTHERMIA; METABOLIC ACIDOSIS; MUSCLE CONTRACTION; MUSCLE WEAKNESS; MUTATIONAL ANALYSIS; PATHOPHYSIOLOGY; PERIOPERATIVE PERIOD; PHARMACOGENETICS; PREOPERATIVE EVALUATION; RECOMMENDED DRUG DOSE; REPEATED DRUG DOSE; RESPIRATORY ACIDOSIS; RHABDOMYOLYSIS; SIDE EFFECT; GENETIC PREDISPOSITION; GENETICS; MUTATION; REVIEW; SYNDROME;

DANTROLENE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALIGNANT HYPERTHERMIA; MUSCLE RELAXANTS, CENTRAL; MUTATION; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; SYNDROME;

EID: 70450210413 PISSN: 01477447 EISSN: None Source Type: Journal
DOI: 10.3928/01477447-20090922-18 Document Type: Article

Times cited : (12)

References (19)

1
- 0020960952
- Current concepts. The malignant hyperthermia syndrome
- Nelson TE, Flewellen EH. Current concepts. The malignant hyperthermia syndrome. N Engl J Med. 1983; 309(7):416-418.
- (1983) N Engl J Med , vol.309 , Issue.7 , pp. 416-418
- Nelson, T.E.¹ Flewellen, E.H.²

2
- 34248376129
- Malignant hyperthermia
- Rosenberg H, Davis M, James D, Pollock N, Stowell K. Malignant hyperthermia. Orphanet J Rare Dis. 2007; 2:21.
- (2007) Orphanet J Rare Dis , vol.2 , pp. 21
- Rosenberg, H.¹ Davis, M.² James, D.³ Pollock, N.⁴ Stowell, K.⁵

3
- 0032480548
- Malignant hyperthermia
- Denborough M. Malignant hyperthermia. Lancet. 1998; 352(9134):1131-1136.
- (1998) Lancet , vol.352 , Issue.9134 , pp. 1131-1136
- Denborough, M.¹

4
- 1542753655
- Malignant hyperthermia
- Ali SZ, Taguchi A, Rosenberg H. Malignant hyperthermia. Best Pract Res Clin Anaesthesiol. 2003; 17(4):519-533.
- (2003) Best Pract Res Clin Anaesthesiol , vol.17 , Issue.4 , pp. 519-533
- Ali, S.Z.¹ Taguchi, A.² Rosenberg, H.³

5
- 0026826784
- Malignant hyperthermia: A review
- Johnson C, Edleman KJ. Malignant hyperthermia: a review. J Perinatol. 1992; 12(1):61-71.
- (1992) J Perinatol , vol.12 , Issue.1 , pp. 61-71
- Johnson, C.¹ Edleman, K.J.²

6
- 0026750306
- Malignant hyperthermia
- Moore JL, Rice EL. Malignant hyperthermia. Am Fam Physician. 1992; 45(5):2245-2251.
- (1992) Am Fam Physician , vol.45 , Issue.5 , pp. 2245-2251
- Moore, J.L.¹ Rice, E.L.²

7
- 0027328613
- Malignant hyperthermia: A review of published cases
- Strazis KP, Fox AW. Malignant hyperthermia: a review of published cases. Anesth Analg. 1993; 77(2):297-304. (Pubitemid 23221428)
- (1993) Anesthesia and Analgesia , vol.77 , Issue.2 , pp. 297-304
- Strazis, K.P.¹ Fox, A.W.²

8
- 0035433910
- Malignant hyperthermia: Perianesthesia recognition, treatment, and care
- DOI 10.1053/jpan.2001.25566
- Redmond MC. Malignant hyperthermia: perianesthesia recognition, treatment, and care. J Perianesth Nurs. 2001; 16(4):259-270. (Pubitemid 33601951)
- (2001) Journal of Perianesthesia Nursing , vol.16 , Issue.4 , pp. 259-270
- Redmond, M.C.¹

9
- 0037406276
- Scanning for mutations of the ryanodine receptor (RYRI) gene by denaturing HPLC: Detection of three novel malignant hyperthermia alleles
- DOI 10.1373/49.5.761
- Tammaro A, Bracco A, Cozzolino S, et al. Scanning for mutations of the ryanodine receptor (RYR1) gene by denaturing HPLC: detection of three novel malignant hyperthermia alleles. Clin Chem. 2003; 49(5):761-768. (Pubitemid 36513255)
- (2003) Clinical Chemistry , vol.49 , Issue.5 , pp. 761-768
- Tammaro, A.¹ Bracco, A.² Cozzolino, S.³ Esposito, M.⁴ Di Martino, A.⁵ Savoia, G.⁶ Zeuli, L.⁷ Piluso, G.⁸ Aurino, S.⁹ Nigro, V.¹⁰

10
- 61549107721
- Genetics and susceptibility to malignant hyperthermia
- quiz 37
- Anderson-Pompa K, Foster A, Parker L, et al. Genetics and susceptibility to malignant hyperthermia. Crit Care Nurse. 2008; 28(6):32-36; quiz 37.
- (2008) Crit Care Nurse , vol.28 , Issue.6 , pp. 32-36
- Anderson-Pompa, K.¹ Foster, A.² Parker, L.³

11
- 0014969922
- Metabolic error of muscle metabolism after recovery from malignant hyperthermia
- Kalow W, Britt BA, Terreau ME, Haist C. Metabolic error of muscle metabolism after recovery from malignant hyperthermia. Lancet. 1970; 2(7679):895-898.
- (1970) Lancet , vol.2 , Issue.7679 , pp. 895-898
- Kalow, W.¹ Britt, B.A.² Terreau, M.E.³ Haist, C.⁴

12
- 0015089198
- Halothane-induced muscle contracture as a cause of hyperpyrexia
- Ellis FR, Harriman DG, Keaney NP, Kyei-Mensah K, Tyrrell JH. Halothane-induced muscle contracture as a cause of hyperpyrexia. Br J Anaesth. 1971; 43(7):721-722.
- (1971) Br J Anaesth , vol.43 , Issue.7 , pp. 721-722
- Ellis, F.R.¹ Harriman, D.G.² Keaney, N.P.³ Kyei-Mensah, K.⁴ Tyrrell, J.H.⁵

13
- 0031951496
- The sensitivity and specificity of the caffeine-halothane contracture test: A report from the North American Malignant Hyperthermia Registry
- The North American Malignant Hyperthermia Registry of MHAUS
- Allen GC, Larach MG, Kunselman AR. The sensitivity and specificity of the caffeine-halothane contracture test: a report from the North American Malignant Hyperthermia Registry. The North American Malignant Hyperthermia Registry of MHAUS. Anesthesiology. 1998; 88(3):579-588.
- (1998) Anesthesiology , vol.88 , Issue.3 , pp. 579-588
- Allen, G.C.¹ Larach, M.G.² Kunselman, A.R.³

14
- 70450124396
- June Accessed June 20, 2009
- Malignant Hyperthermia Association of the United States. June 2009. http://www.mhaus.org/. Accessed June 20, 2009.
- (2009)

15
- 0030873861
- Drug-induced hyperthermia
- Chan TC, Evans SD, Clark RF. Drug-induced hyperthermia. Crit Care Clin. 1997; 13(4):785-808.
- (1997) Crit Care Clin , vol.13 , Issue.4 , pp. 785-808
- Chan, T.C.¹ Evans, S.D.² Clark, R.F.³

16
- 0015466582
- Studies on the mechanism of action of dantrolene sodium. A skeletal muscle relaxant
- Ellis KO, Carpenter JF. Studies on the mechanism of action of dantrolene sodium. A skeletal muscle relaxant. Naunyn Schmiedebergs Arch Pharmacol. 1972; 275(1):83-94.
- (1972) Naunyn Schmiedebergs Arch Pharmacol , vol.275 , Issue.1 , pp. 83-94
- Ellis, K.O.¹ Carpenter, J.F.²

17
- 0015278422
- Excitation-contraction uncoupling in skeletal muscle by dantrolene sodium
- Ellis KO, Bryant SH. Excitation-contraction uncoupling in skeletal muscle by dantrolene sodium. Naunyn Schmiedebergs Arch Pharmacol. 1972; 274(1):107-109.
- (1972) Naunyn Schmiedebergs Arch Pharmacol , vol.274 , Issue.1 , pp. 107-109
- Ellis, K.O.¹ Bryant, S.H.²

18
- 70450138949
- Rochester, MI: JHP Pharmaceuticals
- Dantrolene [package insert]. Rochester, MI: JHP Pharmaceuticals; 2009.
- (2009) Dantrolene [Package Insert]

19
- 0031983278
- Malignant hyperthermia
- Ben Abraham R, Adnet P, Glauber V, Perel A. Malignant hyperthermia. Postgrad Med J. 1998; 74(867):11-17.
- (1998) Postgrad Med J , vol.74 , Issue.867 , pp. 11-17
- Ben Abraham, R.¹ Adnet, P.² Glauber, V.³ Perel, A.⁴

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.